Day 1 in Lund highlighted a clear direction: global policy shifts are increasingly shaping local HTA realities.
External changes, including US MFN policy, are already influencing the pharmaceutical landscape beyond their origin.
Less than a year on, the impact feels well embedded.
At […]
Choosing the right study design for the causal question
We are proud to share that a paper co-authored by Jessica Young is among the Top 10 most-cited papers in Pharmacoepidemiology and Drug Safety for 2024.
The paper, “Core Concepts in Pharmacoepidemiology: New-User Designs,” explores how […]
Expanding our Evidence, Review & Synthesis team
We are pleased to welcome Dr. Gulchehak Kaur to Quantify Research.
Gulchehak joins our Evidence, Review and Synthesis team with a strong foundation across clinical and economic disciplines:
📓Undergraduate degree in Dentistry
📓MSc in Health Economics, Manipal […]
We are pleased to welcome Sami Gabbouj to Quantify Research as Project Leader.
Sami brings more than 10 years of experience across the biomedical field, combining scientific depth with business understanding.
His approach reflects a core challenge in our field:
➡️ translating clinical […]
We are pleased to welcome Emilia Larsson to Quantify Research as Senior HR Business Partner.
Emilia brings ~8 years of HR experience across international organisations in tech, medtech, healthcare, and life sciences.
Her background includes:
• […]
Den 5 maj är Anders Gustavsson vid Quantify med och arrangerar ett digitalt seminarium om hur vi i Sverige kan förbereda oss inför kommande sjukdomsmodifierande behandling vid Alzheimers sjukdom. Den primära målgruppen är kliniskt verksamma inom kognitiva sjukdomar men alla […]
We are pleased to welcome Volmar Kaipainen to Quantify Research as a Research Associate, based in our Helsinki office.
Volmar holds a bachelor’s degree in Econometrics and a master’s degree in Statistics from […]
We have now completed two engaging days at the World Evidence, Pricing and Access Congress
The conversations have been thoughtful, forward-looking, and grounded in the realities of access across Europe.
AI in evidence generation, implementation of Joint Clinical Assessment JCA, and […]
A full and energising first day at the World Evidence, Pricing and Access Congress in Amsterdam.
It was a pleasure to reconnect with long-standing connections, meet new ones, and continue conversations across the access community.
We are pleased to be here […]
📆 Tomorrow (3 March), Béranger Lueza, PhD and Abraham Choong will be in Amsterdam for the World Evidence, Pricing and Access Congress.
📍 You will find us at booth 302, together with our […]